#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14208	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2032	688.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1431	1431	C	863	C	836	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26006	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3588	719.2	0	.	n	.	0	T695C	SNP	695	695	T	1015	1015	C	762	C,T	742,5	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26006	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3588	719.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1657	1657	A	860	A,G,C	846,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26006	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3588	719.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2291	2291	C	811	C,G	779,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26006	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3588	719.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2365	2365	A	859	A	840	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26006	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3588	719.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2917	2917	C	785	C	765	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	132	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1229	10.4	0	.	p	.	0	P12S	NONSYN	34	36	CCC	263	265	TCC	12;12;12	T;C;C	11;11;11	.	Betalactam resistance
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	V36A	NONSYN	106	108	GTG	588	590	GCG	170;170;172	G,A;C;G	165,1;168;168	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	630	632	CGG	175;177;175	C;G;G	170;172;170	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	S68L	NONSYN	202	204	TCG	684	686	TTG	135;133;130	T,C,G;T,C;G	120,1,1;128,1;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	A90V	NONSYN	268	270	GCG	750	752	GTT	126;124;124	G;T;T	121;115;121	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	I105V	NONSYN	313	315	ATT	795	797	GTT	132;129;130	G;T;T	125;115;123	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	N125T	NONSYN	373	375	AAT	855	857	ACC	167;165;163	A;C;C	154;154;154	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	R135C	NONSYN	403	405	CGT	885	887	TGT	157;157;157	T;G;T	139;152;142	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	K151E	NONSYN	451	453	AAA	933	935	GAA	128;128;129	G;A;A	121;125;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	T152N	NONSYN	454	456	ACC	936	938	AAC	130;125;125	A;A;C	128;123;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	A172T	NONSYN	514	516	GCG	996	998	ACA	127;127;127	A;C,A;A	123;125,1;125	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1005	1007	GAA	127;128;130	G;A;A	126;125;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1008	1010	ACC	133;134;135	A,G;C;C	123,1;130;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1014	1016	GTC	138;136;131	G;T;C	134;130;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1044	1046	ACG	140;139;138	A;C;G	131;131;131	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1080	1082	AAC	138;137;138	A;A;C,A	133;130;132,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1140	1142	TTG	146;147;145	T;T;G	143;144;140	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1197	1199	ACC	122;123;123	A;C;C	114;117;120	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1200	1202	GAC	122;121;124	G;A;C	117;114;120	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1209	1211	GCG	129;128;130	G;C;G	127;106;127	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1245	1247	GCT	120;119;121	G;C,G;T	119;112,1;110	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1472	folP	858	858	91.61	folP.l15.c4.ctg.1	1676	87.4	1	SNP	p	R230S	1	.	.	688	690	AGC	1170	1172	AGC	159;159;159	A;G;C	152;153;150	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	138.0	1	SNP	p	S91F	0	.	.	271	273	TCC	594	596	TCC	177;178;178	T;C,A;C,G	173;174,1;171,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	138.0	1	SNP	p	D95N	0	.	.	283	285	GAC	606	608	GAC	178;178;178	G;A,T;C	174;169,1;175	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4754	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3419	138.0	1	SNP	p	D95G	0	.	.	283	285	GAC	606	608	GAC	178;178;178	G;A,T;C	174;169,1;175	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1520	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1282	117.3	1	SNP	p	G45D	1	.	.	133	135	GAC	442	444	GAC	183;184;185	G;A,G;C	178;176,1;180	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	862	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	994	85.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	144.7	1	SNP	p	D86N	0	.	.	256	258	GAC	593	595	GAC	174;174;177	G;A;C	168;162;172	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	144.7	1	SNP	p	S87R	0	.	.	259	261	AGT	596	598	AGT	175;175;175	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	144.7	1	SNP	p	S87W	0	.	.	259	261	AGT	596	598	AGT	175;175;175	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	144.7	1	SNP	p	S87I	0	.	.	259	261	AGT	596	598	AGT	175;175;175	A;G;T	170;170;169	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4416	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3028	144.7	1	SNP	p	S88P	0	.	.	262	264	TCC	599	601	TCC	172;178;179	T;C;C	167;170;171	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3762	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2723	137.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	157;157;159	G;G;C	154;157;157	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1284	1286	GCC	200;198;200	G;C;C	197;195;195	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1287	1289	ATG	201;201;201	A;T;G	199;195;198	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1299	1301	ACC	205;202;206	A;C;C	195;199;201	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1299	1301	ACC	205;202;206	A;C;C	195;199;201	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1800	1802	ACC	185;185;187	A;C;C	170;175;177	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1854	1856	GCG	192;192;193	G;C;G	187;189;187	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1854	1856	GCG	192;192;193	G;C;G	187;189;187	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1977	1979	GGT	149;146;145	G;G;T	143;140;136	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1986	1988	AGC	138;135;131	A;G;C	132;130;124	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3786	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2432	154.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2004	2006	CCG	105;108;108	C,G;C;G,C	96,3;100;93,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5186	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3182	161.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2070	porA	1146	1146	99.83	porA.l6.c4.ctg.1	1768	115.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	566	566	C	130	C	126	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2710	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1620	165.9	0	.	p	.	0	E41K	NONSYN	121	123	GAA	468	470	AAA	194;194;195	A,G;A;A	184,4;192;192	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2710	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1620	165.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	978	978	T	228	T,A	215,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2710	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1620	165.9	1	SNP	p	G120K	0	.	.	358	360	GGT	705	707	GGT	206;207;207	G,A;G,A;T,G	199,1;203,1;199,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2710	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1620	165.9	1	SNP	p	A121N	0	.	.	361	363	GCC	708	710	GCC	207;206;207	G,A;C,A;C	200,2;203,1;202	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2710	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1620	165.9	1	SNP	p	A121D	0	.	.	361	363	GCC	708	710	GCC	207;206;207	G,A;C,A;C	200,2;203,1;202	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9682	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4888	196.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1952	1954	CAT	199;194;194	C;A;T	192;190;189	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1064	107.2	1	SNP	p	V57M	1	.	.	169	171	ATG	617	619	ATG	236;235;233	A;T;G	233;231;232	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
